What is Crinetics Pharmaceuticals, Inc.'s Market Cap?

Crinetics Pharmaceuticals, Inc.'s Market Cap is $9.0B, based on as-reported figures from SEC (XBRL) filings.

What is Crinetics Pharmaceuticals, Inc.'s Enterprise Value?

Crinetics Pharmaceuticals, Inc.'s Enterprise Value is $7.8B, based on as-reported figures from SEC (XBRL) filings.

What is Crinetics Pharmaceuticals, Inc.'s Price / Sales?

Crinetics Pharmaceuticals, Inc.'s Price / Sales is 213.7×, based on as-reported figures from SEC (XBRL) filings.

What is Crinetics Pharmaceuticals, Inc.'s EV / Revenue?

Crinetics Pharmaceuticals, Inc.'s EV / Revenue is 185.1×, based on as-reported figures from SEC (XBRL) filings.

What is Crinetics Pharmaceuticals, Inc.'s EV / EBITDA?

Crinetics Pharmaceuticals, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Crinetics Pharmaceuticals, Inc.'s Revenue (TTM)?

Crinetics Pharmaceuticals, Inc.'s Revenue (TTM) is $42.2M, based on as-reported figures from SEC (XBRL) filings.

What is Crinetics Pharmaceuticals, Inc.'s Net Income (TTM)?

Crinetics Pharmaceuticals, Inc.'s Net Income (TTM) is -$501.6M, based on as-reported figures from SEC (XBRL) filings.

What is Crinetics Pharmaceuticals, Inc.'s EBITDA?

Crinetics Pharmaceuticals, Inc.'s EBITDA is -$544.9M, based on as-reported figures from SEC (XBRL) filings.

What is Crinetics Pharmaceuticals, Inc.'s Diluted EPS (TTM)?

Crinetics Pharmaceuticals, Inc.'s Diluted EPS (TTM) is -4.73, based on as-reported figures from SEC (XBRL) filings.

What is Crinetics Pharmaceuticals, Inc.'s EBITDA Margin?

Crinetics Pharmaceuticals, Inc.'s EBITDA Margin is -1292.5%, based on as-reported figures from SEC (XBRL) filings.

Crinetics Pharmaceuticals, Inc. (CRNX) Financial Statements

Crinetics Pharmaceuticals, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00BC592C3

XNAS · usd

84.95▲ 0.11 (0.13%)

As of 2026-08-31

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close84.84

Day's Range84.92 – 85.01

52-Week Range31.00 – 85.01

Volume8.2M

Avg Volume2.7M

Share Statistics

Shares Outstanding

Employees594

ExchangeXNAS

Listed2018-07-18

Share count as of July 22, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Crinetics Pharmaceuticals, Inc. (CRNX)

What is Crinetics Pharmaceuticals, Inc.'s Market Cap?: Crinetics Pharmaceuticals, Inc.'s Market Cap is $9.0B, based on as-reported figures from SEC (XBRL) filings.
What is Crinetics Pharmaceuticals, Inc.'s Enterprise Value?: Crinetics Pharmaceuticals, Inc.'s Enterprise Value is $7.8B, based on as-reported figures from SEC (XBRL) filings.
What is Crinetics Pharmaceuticals, Inc.'s Price / Sales?: Crinetics Pharmaceuticals, Inc.'s Price / Sales is 213.7×, based on as-reported figures from SEC (XBRL) filings.
What is Crinetics Pharmaceuticals, Inc.'s EV / Revenue?: Crinetics Pharmaceuticals, Inc.'s EV / Revenue is 185.1×, based on as-reported figures from SEC (XBRL) filings.
What is Crinetics Pharmaceuticals, Inc.'s EV / EBITDA?: Crinetics Pharmaceuticals, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Crinetics Pharmaceuticals, Inc.'s Revenue (TTM)?: Crinetics Pharmaceuticals, Inc.'s Revenue (TTM) is $42.2M, based on as-reported figures from SEC (XBRL) filings.
What is Crinetics Pharmaceuticals, Inc.'s Net Income (TTM)?: Crinetics Pharmaceuticals, Inc.'s Net Income (TTM) is -$501.6M, based on as-reported figures from SEC (XBRL) filings.
What is Crinetics Pharmaceuticals, Inc.'s EBITDA?: Crinetics Pharmaceuticals, Inc.'s EBITDA is -$544.9M, based on as-reported figures from SEC (XBRL) filings.
What is Crinetics Pharmaceuticals, Inc.'s Diluted EPS (TTM)?: Crinetics Pharmaceuticals, Inc.'s Diluted EPS (TTM) is -4.73, based on as-reported figures from SEC (XBRL) filings.
What is Crinetics Pharmaceuticals, Inc.'s EBITDA Margin?: Crinetics Pharmaceuticals, Inc.'s EBITDA Margin is -1292.5%, based on as-reported figures from SEC (XBRL) filings.